Samsung knows that you can't get blood from a turnip, and they are better off waiting to be paid in full, rather than driving CYDY into bankruptcy when CYDY is on the verge of getting a settlement from Amarex that could fund breakthrough clinical trials.

What I found most surprising was the agreement NOT to charge interest.